CRISPR: Hope or hype?

The first CRISPR clinical trials are expected to start before the end of the year. But scientists have found that the technique might, in some circumstances, pose unexpected risks to patients. Join us for a panel discussion in Boston on Oct. 9 — led by Senior Science Writer Sharon Begley — that explores the newest forms and uses of CRISPR, its potential to cure now-incurable diseases, and the challenges of turning a revolutionary lab technique into a therapy. Coffee and snacks will be provided. Register today.